ISRCTN is a company limited by guarantee with the Directors listed below. The ISRCTN registry is administered and the database is hosted and published on behalf of ISRCTN by BioMed Central, a publisher of open access peer-reviewed biomedical journals. BioMed Central is owned by Springer Science+Business Media. The Board of Directors delegates day-to-day management of the registry and database to the editorial team at BioMed Central Ltd. It also has the benefit of advice from an international advisory group.

Board of Directors

  • Caroline Black, formerly BioMed Central, UK
  • Matt Cockerill, formerly BioMed Central, UK
  • Jim Smith, Wellcome Trust
  • Marc Taylor, formerly Department of Health, UK (chair)
  • Tom Walley, University of Liverpool

Advisory Group

  • Doug Altman, University of Oxford, UK
  • Gerd Antes, Cochrane Centre, Germany
  • Maurizio Bonati, Mario Negri Institute for Pharmacological Research, Italy
  • An-Wen Chan, University of Toronto, Canada
  • Mike Clarke, Queen's University Belfast, UK
  • Simon Denegri, INVOLVE, UK
  • Kay Dickersin, Johns Hopkins Bloomberg School of Public Health, USA
  • Jeffrey Drazen, New England Journal of Medicine, USA
  • Lelia Duley, University of Nottingham, UK
  • Maria Grazia Franzosi, Mario Negri Institute for Pharmacological Research, Italy
  • Ben Goldacre, London School of Hygiene and Tropical Medicine, UK
  • Sally Hopewell, University of Oxford, UK
  • Karmela Krleza-Jeric, Ottawa Group-IMPACT (Canada) and University of Split School of Medicine, Croatia
  • Carol Lefebvre, Information consultant, UK
  • Richard Lilford, University of Birmingham, UK
  • David Moher, Ottawa Hospital Research Institute, Canada
  • Chiara Pandolfini, Mario Negri Institute for Pharmacological Research, Italy
  • Lesley Stewart, University of York, UK
  • Marc Taylor, Formerly Department of Health, UK
  • Emma Veitch, Public Library of Science, UK
  • Elizabeth Wager, Publications consultant, UK
  • Paul Wicks, Patientslikeme, USA

June 2018